Ivor Royston Viracta Therapeutics, Inc. (VIRX) insider trading activity

Ivor Royston is of Viracta Therapeutics, Inc.. Currently has a direct ownership of 839,741 shares of VIRX, which is worth approximately $176,345. The most recent transaction as insider was on Nov 25, 2024, when has been sold 25,219 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 840K

3.1% 3M change

13.65% 12M change

Total Value Held $176,345

IVOR ROYSTON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 25 2024	BUY Exercise of conversion of derivative security	-	25,219 Added 2.92%	839,741 Common Stock
Aug 25 2024	BUY Exercise of conversion of derivative security	-	25,219 Added 3.0%	814,522 Common Stock
May 25 2024	BUY Exercise of conversion of derivative security	-	25,219 Added 3.1%	789,303 Common Stock
Feb 25 2024	BUY Exercise of conversion of derivative security	-	25,219 Added 3.2%	764,084 Common Stock
Nov 25 2023	BUY Exercise of conversion of derivative security	-	25,219 Added 3.3%	738,865 Common Stock
Aug 25 2023	BUY Exercise of conversion of derivative security	-	25,219 Added 3.41%	713,646 Common Stock
May 25 2023	BUY Exercise of conversion of derivative security	-	25,219 Added 3.53%	688,427 Common Stock
Feb 25 2023	BUY Exercise of conversion of derivative security	-	25,219 Added 3.66%	663,208 Common Stock
Nov 25 2022	BUY Exercise of conversion of derivative security	-	25,219 Added 3.8%	637,989 Common Stock
Aug 26 2022	SELL Open market or private sale	$53,650 $4.01 p/Share	13,379 Reduced 2.14%	612,770 Common Stock
Aug 25 2022	BUY Exercise of conversion of derivative security	-	25,219 Added 3.87%	626,149 Common Stock
May 26 2022	SELL Open market or private sale	$25,008 $1.9 p/Share	13,162 Reduced 2.14%	600,930 Common Stock
May 25 2022	BUY Exercise of conversion of derivative security	-	25,219 Added 3.94%	614,092 Common Stock
Feb 28 2022	SELL Open market or private sale	$40,685 $2.78 p/Share	14,635 Reduced 2.42%	588,873 Common Stock
Feb 25 2022	BUY Exercise of conversion of derivative security	-	25,219 Added 4.01%	603,508 Common Stock
Dec 29 2021	BUY Exercise of conversion of derivative security	$6,300 $0.9 p/Share	7,000 Added 1.2%	578,289 Common Stock
Nov 29 2021	SELL Open market or private sale	$76,315 $4.82 p/Share	15,833 Reduced 2.7%	571,289 Common Stock
Nov 26 2021	SELL Open market or private sale	$57,187 $4.8 p/Share	11,914 Reduced 1.99%	587,122 Common Stock
Nov 25 2021	BUY Exercise of conversion of derivative security	-	50,437 Added 7.77%	599,036 Common Stock
Nov 15 2021	BUY Open market or private purchase	$44,480 $5.56 p/Share	8,000 Added 1.44%	548,599 Common Stock

Also insider at

BIOC

BIOCEPT INC Healthcare

Director

Ivor Royston

Cardiff, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIRX shares.

Notify only if

Value

Insider Trading

Get notified when an Viracta Therapeutics, Inc. insider buys or sells VIRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Viracta Therapeutics, Inc.

Track Activities on VIRX

Account